<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37064319</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2398-8835</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Health science reports</Title><ISOAbbreviation>Health Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Post-COVID-19-associated multiorgan complications or "long COVID" with literature review and management strategy discussion: A meta-analysis.</ArticleTitle><Pagination><StartPage>e1211</StartPage><MedlinePgn>e1211</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e1211</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/hsr2.1211</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To investigate the post-COVID-19 long-term complications or long COVID of various organ systems in patients after 3 months of the infection, specifically before the Omicron variant, with comparative literature analysis.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A systemic literature search and meta-analysis were conducted using multiple electronic databases (PubMed, Scopus, Cochrane library) with predefined search terms to identify eligible articles. Eligible studies reported long-term complications of COVID-19 infection before the Omicron variant infection. Case reports, case series, observational studies with cross-sectional or prospective research design, case-control studies, and experimental studies that reported post-COVID-19 complications were included. The complications reported after 3 months after the recovery from COVID-19 infection were included in the study.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The total number of studies available for analysis was 34. The effect size (ES) for neurological complications was 29% with 95% confidence interval (CI): 19%-39%. ES for psychiatric complications was 24% with 95% CI: 7%-41%. ES was 9% for cardiac outcomes, with a 95% CI of 1%-18%. ES was 22%, 95% CI: 5%-39% for the gastrointestinal outcome. ES for musculoskeletal symptoms was 18% with 95% CI: 9%-28%. ES for pulmonary complications was 28% with 95% CI: 18%-37%. ES for dermatological complications was 25%, with a 95% CI of 23%-26%. ES for endocrine outcomes was 8%, with a 95% CI of 8%-9%. ES size for renal outcomes was 3% with a 95% CI of 1%-7%. At the same time, other miscellaneous uncategorized outcomes had ES of 39% with 95% CI of&#xa0;21%-57%. Apart from analyzing COVID-19 systemic complications outcomes, the ES for hospitalization and intensive&#xa0;care unit&#xa0;admissions were found to be 4%, 95% CI: 0%-7%, and 11% with 95% CI: 8%-14%.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">By acquiring the data and statistically analyzing the post-COVID-19 complications during the prevalence of most virulent strains, this study has generated a different way of understanding COVID-19 and its complications for better community health.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Health Science Reports published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Iqbal</LastName><ForeName>Phool</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine New York Medical College/Metropolitan Hospital Center New York New York USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ata</LastName><ForeName>Fateen</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-7121-8574</Identifier><AffiliationInfo><Affiliation>Department of Endocrinology Hamad Medical Corporation Doha Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaudhry</LastName><ForeName>Hassan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine University Hospital of Leicester Leicester UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muthanna</LastName><ForeName>Bassam</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Geriatrics University of Illinois at Chicago Chicago Illinois USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waqas Younas</LastName><ForeName>Hafiz</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>NHS Lanarkshire Leicester UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munamm</LastName><ForeName>Syed Ata Ul</ForeName><Initials>SAU</Initials><AffiliationInfo><Affiliation>Department of Public Health Health Services Academy Islamabad Islamabad Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Rohit</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine Geisinger Health System Danville Pennsylvania USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fadah</LastName><ForeName>Kahtan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine Texas Tech University Health Sciences Center El Paso Lubbock Texas USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elazzazy</LastName><ForeName>Shereen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Pharmacy Department National Centre for Cancer Care and Research, Hamad Medical Corporation Doha Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamad</LastName><ForeName>Anas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Clinical Pharmacology National Centre for Cancer Care and Research, Hamad Medical Corporation Doha Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Said Abu Tabar</LastName><ForeName>Osama</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Cleveland Clinic Abu Dhabi, Clinical Assistant Professor of Medicine, Cleveland Clinic Lerner College of Medicine Case Western Reserve University Abu Dhabi UAE.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Omar</LastName><ForeName>Nabil E</ForeName><Initials>NE</Initials><Identifier Source="ORCID">0000-0001-8291-7987</Identifier><AffiliationInfo><Affiliation>Pharmacy Department National Centre for Cancer Care and Research, Hamad Medical Corporation Doha Qatar.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Health Sci Rep</MedlineTA><NlmUniqueID>101728855</NlmUniqueID><ISSNLinking>2398-8835</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID&#x2010;19 complications</Keyword><Keyword MajorTopicYN="N">Meta&#x2010;analysis</Keyword><Keyword MajorTopicYN="N">Post&#xa0;COVID&#x2010;19</Keyword><Keyword MajorTopicYN="N">SARS&#x2010;CoV&#x2010;2&#xa0;sequelae</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>17</Day><Hour>3</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37064319</ArticleId><ArticleId IdType="pmc">PMC10103688</ArticleId><ArticleId IdType="doi">10.1002/hsr2.1211</ArticleId><ArticleId IdType="pii">HSR21211</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
Long COVID: long&#x2010;term effects of COVID&#x2010;19
. Johns Hopkins Medicine. Accessed August 1, 2022.&#xa0;. Accessed August 1, 2022. (june, 2022) https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus/covid-long-haulers-long-term-effects-of-covid19
</Citation></Reference><Reference><Citation>Sabetkish N, Rahmani A. The overall impact of COVID&#x2010;19 on healthcare during the pandemic: a multidisciplinary point of view. Health Sci Rep. 2021;4(4). 10.1002/HSR2.386</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/HSR2.386</ArticleId><ArticleId IdType="pmc">PMC8485600</ArticleId><ArticleId IdType="pubmed">34622020</ArticleId></ArticleIdList></Reference><Reference><Citation>Couzin&#x2010;Frankel J. Clues to long COVID. Science. 2022;376(6599):1261&#x2010;1265. 10.1126/SCIENCE.ADD4297</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/SCIENCE.ADD4297</ArticleId><ArticleId IdType="pubmed">35709281</ArticleId></ArticleIdList></Reference><Reference><Citation>
Long COVID or post&#x2010;COVID conditions
. CDC. Accessed August 9, 2022. https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html
</Citation></Reference><Reference><Citation>
Omicron, Delta, Alpha, and More: what to know about the coronavirus variants
. Yale Medicine. Accessed July 27, 2022. Accessed July 27, 2022. https://www.yalemedicine.org/news/covid-19-variants-of-concern-omicron
</Citation></Reference><Reference><Citation>Br&#xfc;ssow H. COVID&#x2010;19: Omicron&#x2014;the latest, the least virulent, but probably not the last variant of concern of SARS&#x2010;CoV&#x2010;2. Microb Biotechnol. 2022;15(7):1927&#x2010;1939. 10.1111/1751-7915.14064</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1751-7915.14064</ArticleId><ArticleId IdType="pmc">PMC9111164</ArticleId><ArticleId IdType="pubmed">35443078</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins M, do Nascimento GM, Nooruzzaman M, et al. The Omicron variant BA.1.1 presents a lower pathogenicity than B.1 D614G and Delta variants in a feline model of SARS&#x2010;CoV&#x2010;2 infection. bioRxiv. 2022. 10.1101/2022.06.15.496220</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.06.15.496220</ArticleId><ArticleId IdType="pmc">PMC9472624</ArticleId><ArticleId IdType="pubmed">36000850</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandrashekar A, Yu J, McMahan K, et al. Vaccine protection against the SARS&#x2010;CoV&#x2010;2 Omicron variant in macaques. Cell. 2022;185(9):1549&#x2010;1555. 10.1016/J.CELL.2022.03.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CELL.2022.03.024</ArticleId><ArticleId IdType="pmc">PMC8926910</ArticleId><ArticleId IdType="pubmed">35427477</ArticleId></ArticleIdList></Reference><Reference><Citation>Nersesjan V, Amiri M, Lebech AM, et al. Central and peripheral nervous system complications of COVID&#x2010;19: a prospective tertiary center cohort with 3&#x2010;month follow&#x2010;up. J Neurol. 2021;268(9):3086&#x2010;3104. 10.1007/S00415-020-10380-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S00415-020-10380-X</ArticleId><ArticleId IdType="pmc">PMC7803470</ArticleId><ArticleId IdType="pubmed">33438076</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera JA, Valdes E, Huang J, et al. Prevalence and impact of hyponatremia in patients with coronavirus disease 2019 in New York City. Crit Care Med. 2020;48(12):e1211&#x2010;e1217. 10.1097/CCM.0000000000004605</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004605</ArticleId><ArticleId IdType="pmc">PMC7467047</ArticleId><ArticleId IdType="pubmed">32826430</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID&#x2010;19). JAMA Cardiol. 2020;5(11):1265&#x2010;1273. 10.1001/JAMACARDIO.2020.3557</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/JAMACARDIO.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal DEFP, Laswi BE, Bilal Jamshaid ME, et al. The role of anticoagulation in post&#x2010;COVID&#x2010;19 concomitant stroke, myocardial infarction, and left ventricular thrombus: a case report. Am J Case Rep. 2021;22:e928852. 10.12659/AJCR.928852</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/AJCR.928852</ArticleId><ArticleId IdType="pmc">PMC7816663</ArticleId><ArticleId IdType="pubmed">33446625</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6&#x2010;month consequences of COVID&#x2010;19 in patients discharged from hospital: a cohort study. The Lancet. 2021;397(10270):220&#x2010;232. 10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Demelo&#x2010;Rodr&#xed;guez P, Ordieres&#x2010;Ortega L, Ji Z, et al. Long&#x2010;term follow&#x2010;up of patients with venous thromboembolism and COVID&#x2010;19: analysis of risk factors for death and major bleeding. Eur J Haematol. 2021;106(5):716&#x2010;723. 10.1111/EJH.13603</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/EJH.13603</ArticleId><ArticleId IdType="pmc">PMC8013455</ArticleId><ArticleId IdType="pubmed">33608914</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin LB, Weinstock LB, Molderings GJ. Covid&#x2010;19 hyperinflammation and post&#x2010;Covid&#x2010;19 illness may be rooted in mast cell activation syndrome. Int J Infect Dis. 2020;100:327&#x2010;332. 10.1016/J.IJID.2020.09.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.IJID.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7529115</ArticleId><ArticleId IdType="pubmed">32920235</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta&#x2010;analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. 10.1371/JOURNAL.PMED.1000097</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/JOURNAL.PMED.1000097</ArticleId><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroup DF, Berlin JA, Morton SC, et al. Meta&#x2010;analysis of observational studies in epidemiology: a proposal for reporting. meta&#x2010;analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283(15):2008&#x2010;2012. 10.1001/JAMA.283.15.2008</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/JAMA.283.15.2008</ArticleId><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronavirus disease (COVID&#x2010;19): post COVID&#x2010;19 condition. World Health Organization.&#xa0;Accessed August 1, 2022.&#xa0;https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-post-covid-19-condition
</Citation></Reference><Reference><Citation>Omicron variant: what you need to know. CDC. Accessed July 28, 2022. https://www.cdc.gov/coronavirus/2019-ncov/variants/omicron-variant.html
</Citation></Reference><Reference><Citation>Iqbal P, Laswi B, Jamshaid MB, et al. The role of anticoagulation in post&#x2010;COVID&#x2010;19 concomitant stroke, myocardial infarction, and left ventricular thrombus: a case report. Am J Case Rep. 2021;22(1):928852. 10.12659/AJCR.928852</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/AJCR.928852</ArticleId><ArticleId IdType="pmc">PMC7816663</ArticleId><ArticleId IdType="pubmed">33446625</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO coronavirus (COVID&#x2010;19) dashboard with vaccination data. WHO. Accessed July 28, 2022. https://covid19.who.int/
</Citation></Reference><Reference><Citation>Long COVID or post&#x2010;COVID conditions. CDC. Accessed July 30, 2022. https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html
</Citation></Reference><Reference><Citation>Xiong Q, Xu M, Li J, et al. Clinical sequelae of COVID&#x2010;19 survivors in Wuhan, China: a single&#x2010;centre longitudinal study. Clin Microbiol Infect. 2021;27(1):89&#x2010;95. 10.1016/J.CMI.2020.09.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CMI.2020.09.023</ArticleId><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Denina M, Pruccoli G, Scolfaro C, et al. Sequelae of COVID&#x2010;19 in hospitalized children: a 4&#x2010;months follow&#x2010;up. Pediatr Infect Dis J. 2020;39(12):e458&#x2010;e459. 10.1097/INF.0000000000002937</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000002937</ArticleId><ArticleId IdType="pubmed">33003103</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge Y, Zhang WB, Liu H, et al. Effects of worldwide interventions and vaccination on COVID&#x2010;19 between waves and countries. medRxiv. 2021. 10.1101/2021.03.31.21254702</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.31.21254702</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald LT. Healing after COVID&#x2010;19: are survivors at risk for pulmonary fibrosis? Am J Physiol Lung Cell Mol Physiol. 2021;320(2):L257&#x2010;L265. 10.1152/AJPLUNG.00238.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/AJPLUNG.00238.2020</ArticleId><ArticleId IdType="pmc">PMC7900916</ArticleId><ArticleId IdType="pubmed">33355522</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhassan SM, Iqbal P, Fikrey L, et al. Post COVID 19 acute acalculous cholecystitis raising the possibility of underlying dysregulated immune response, a case report. Ann Med Surg. 2020;60:434&#x2010;437. 10.1016/J.AMSU.2020.11.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.AMSU.2020.11.031</ArticleId><ArticleId IdType="pmc">PMC7664478</ArticleId><ArticleId IdType="pubmed">33224493</ArticleId></ArticleIdList></Reference><Reference><Citation>Han MW, Wang M, Xu MY, Qi WP, Wang P, Xi D. Clinical features and potential mechanism of coronavirus disease 2019&#x2010;associated liver injury. World J Clin Cases. 2021;9(3):528&#x2010;539. 10.12998/WJCC.V9.I3.528</Citation><ArticleIdList><ArticleId IdType="doi">10.12998/WJCC.V9.I3.528</ArticleId><ArticleId IdType="pmc">PMC7829721</ArticleId><ArticleId IdType="pubmed">33553391</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortelli P, Ferrazzoli D, Sebastianelli L, et al. Neuropsychological and neurophysiological correlates of fatigue in post&#x2010;acute patients with neurological manifestations of COVID&#x2010;19: insights into a challenging symptom. J Neurol Sci. 2021;420:117271. 10.1016/J.JNS.2020.117271</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JNS.2020.117271</ArticleId><ArticleId IdType="pmc">PMC7834526</ArticleId><ArticleId IdType="pubmed">33359928</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall J, Myall K, Lam JL, et al. Identifying patients at risk of post&#x2010;discharge complications related to COVID&#x2010;19 infection. Thorax. 2021;76(4):408&#x2010;411. 10.1136/THORAXJNL-2020-215861</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/THORAXJNL-2020-215861</ArticleId><ArticleId IdType="pubmed">33542090</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan FJ, Hope CM, Masavuli MG, et al. Long&#x2010;term perturbation of the peripheral immune system months after SARS&#x2010;CoV&#x2010;2 infection. BMC Med. 2022;20(1):26. 10.1186/S12916-021-02228-6/FIGURES/4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S12916-021-02228-6/FIGURES/4</ArticleId><ArticleId IdType="pmc">PMC8758383</ArticleId><ArticleId IdType="pubmed">35027067</ArticleId></ArticleIdList></Reference><Reference><Citation>
RACGP
. Even mild COVID can have &#x2018;lasting&#x2019; effects on immune system: study. Accessed July 31, 2022. https://www1.racgp.org.au/newsgp/clinical/even-mild-covid-cases-can-have-lasting-effects-on
</Citation></Reference><Reference><Citation>Castanares&#x2010;Zapatero D, Chalon P, Kohn L, et al. Pathophysiology and mechanism of long COVID: a comprehensive review. Ann Med. 2022;54(1):1473&#x2010;1487. 10.1080/07853890.2022.2076901</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez&#x2010;Leon S, Wegman&#x2010;Ostrosky T, Perelman C, et al. More than 50 long&#x2010;term effects of COVID&#x2010;19: a systematic review and meta&#x2010;analysis. Sci Rep. 2021;11(1):16144. 10.1038/s41598-021-95565-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q, Zheng B, Daines L, Sheikh A. Long&#x2010;term sequelae of COVID&#x2010;19: a systematic review and meta&#x2010;analysis of one&#x2010;year follow&#x2010;up studies on post&#x2010;COVID symptoms. Pathogens. 2022;11(2):269. 10.3390/PATHOGENS11020269/S1</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/PATHOGENS11020269/S1</ArticleId><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, et al. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6(9):e005427. 10.1136/BMJGH-2021-005427</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJGH-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D, Moschopoulos CD, Margalit I, et al. ESCMID rapid guidelines for assessment and management of long COVID. Clin Microbiol Infect. 2022;28(7):955&#x2010;972. 10.1016/J.CMI.2022.02.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CMI.2022.02.018</ArticleId><ArticleId IdType="pmc">PMC8849856</ArticleId><ArticleId IdType="pubmed">35182760</ArticleId></ArticleIdList></Reference><Reference><Citation>
Biden&#x2013;Harris administration releases two new reports on long COVID to support patients and further research. HHS.gov
. Accessed August 9, 2022. https://www.hhs.gov/about/news/2022/08/03/biden-harris-administration-releases-two-new-reports-long-covid-support-patients-further-research.html
</Citation></Reference><Reference><Citation>
Long COVID treatment
. UCLA Health. Accessed August 9, 2022. https://www.uclahealth.org/medical-services/long-covid
</Citation></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid&#x2014;mechanisms, risk factors, and management. BMJ. 2021;374:1648. 10.1136/BMJ.N1648</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJ.N1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Al&#x2010;Tawfiq JA, Hoang VT, Le Bui N, Chu DT, Memish ZA. The emergence of the omicron (B.1.1.529) SARS&#x2010;CoV&#x2010;2 variant: what is the impact on the continued pandemic? J Epidemiol Glob Health. 2022;12(2):143&#x2010;146. 10.1007/s44197-022-00032-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s44197-022-00032-w</ArticleId><ArticleId IdType="pmc">PMC8795715</ArticleId><ArticleId IdType="pubmed">35089588</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG. Quantifying heterogeneity in a meta&#x2010;analysis. Stat Med. 2002;21(11):1539&#x2010;1558. 10.1002/sim.1186</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1186</ArticleId><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>